抗衰老药物和相关的信号通路
Nannan Du1,2, Ruigang Yang1,2,3, Shengrong Jiang4
1Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China.
Biomedicines
|January 23, 2024
概括
本综述探讨了关键的衰老途径和针对它们的药物. 它强调了像拉巴素和甲胺这样的药物如何为缓解衰老和基于机制的干预提供了可访问的策略.
科学领域:
- 老年学和分子生物学.
- 专注于衰老和治疗干预的生物机制.
背景情况:
- 衰老是一个复杂的过程,与慢性疾病有关,从分子到系统水平影响个人.
- 存在各种干预措施,包括饮食改变,运动和药物,抗衰老药物提供了易于使用和可访问性.
研究的目的:
- 审查关键的与衰老相关的信号通路及其向药物.
- 为开发基于机制的抗衰老策略提供见解.
主要方法:
- 在PubMed,Web of Science,EBSCO和Cochrane图书馆数据库中进行全面的文献搜索,截至2022年5月31日.
- 识别了15983个相关的文章进行分析.
主要成果:
- 确定了六个关键的衰老途径:mTOR,AMPK,营养信号传递,SIRT1,端粒长度调节和GSK-3/能量代谢.
- 针对这些途径的代表性药物包括拉巴素,甲福明,阿卡尔,NAD+,和NSAIDs.
结论:
- 针对不同途径的抗衰老药物可以缓解衰老.
- 了解路径交叉对推进基于机制的抗衰老疗法至关重要.
相关概念视频
Aging
52
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
52
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Signal Transduction: Overview
8.5K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
8.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


